Biomarkers of Atopy Beginning Early (BABE)

特应性早期开始的生物标志物 (BABE)

基本信息

  • 批准号:
    10633364
  • 负责人:
  • 金额:
    $ 145.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-07 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT – OVERALL Atopic dermatitis (AD) often precedes sensitization to food allergens and the development of clinical food allergy (FA) due to compromised skin barrier function allowing allergen sensitization through skin. A large body of data from Europe and North America suggest that living on farms is associated with a decreased risk of asthma and atopic diseases. Asthma has been a focus of farming lifestyle studies; however, little is known about the protective mechanisms of farming lifestyle on development of AD and FA which often precede respiratory allergies and asthma. The farm lifestyle protection against allergic diseases comprises likely three prerequisites: 1) innate immune training and a modified immune response upon re-exposure, 2) generation of suppressive regulatory T cells, and 3) preserved barrier function. Here, we propose to assess these preconditions in an extended longitudinal birth cohort study among the Old Order Mennonites (OOM), a population practicing traditional, single-family farming with a lower rate of asthma and allergic diseases, including atopic dermatitis and food allergies in early childhood. Biomarkers of Atopy Beginning Early (BABE) will test the overall hypothesis that perturbed skin barrier function, immune millieu and microbiome drive the development of atopic dermatitis, Th2 inflammation, allergic sensitization and FA, whereas a healthy gut microbiome modulates the protective metabolite pool such as short chain fatty acids and tryptophan metabolites and protective Treg immune development. Project 1 utilizes deep metagenomic sequencing to assess infant gut microbiome composition and corresponding metabolome to show that OOM infant gut microbiome is distinct from urban infants. Project 2 assesses markers of allergic sensitization and protective immune development utilizing multiparameter spectral flow, unbiased clustering analysis and transcriptomic studies to demonstrate that urban infants have a higher number of hyperinflammatory monocytes and Th2-skewed T cell subsets detected in early infancy, whereas OOM have gut-homing memory Tregs. Project 3 will characterize skin barrier function, microbiome and immune cell transcriptome. Our longitudinal birth cohort ZOOM1, funded by a U01 grant, is now 2-5 years old and is a shared foundation for the three projects (78 OOM and 79 urban). We will add another 120 infants as a ZOOM2 cohort (80 urban and 40 OOM). We will also replicate key T cell biomarkers in larger infant cohorts (Start Eating Early Diet ”SEED” and Microbiome and Allergic Asthma Precision Prevention “MAAP2”). The infrastructure to recruit, collect and share samples and data is provided by the Cohort Admin & Biorepository and Data Management & Bioinformatics Cores. The Admin Core will provide overall financial and administrative infrastructure. These studies aim to identify biomarkers, mechanisms, and protective strategies against atopic and food allergy.
项目摘要/摘要--总体 特应性皮炎(AD)通常先于对食物过敏原的致敏和临床食物过敏的发展。 (FA)由于皮肤屏障功能受损,导致过敏原通过皮肤致敏。一大堆数据 来自欧洲和北美的研究表明,住在农场与哮喘风险的降低和 特应性疾病。哮喘一直是农业生活方式研究的焦点;然而,对哮喘的研究知之甚少。 耕作生活方式对AD和FA发病的保护机制 过敏和哮喘。农场生活方式对过敏性疾病的保护可能包括三个先决条件: 1)先天免疫训练和再次暴露时的改良免疫反应,2)产生抑制 调节性T细胞;3)保护屏障功能。在这里,我们建议在一个 实践种群旧秩序门诺派(OOM)的扩展纵向出生队列研究 传统的单一家庭养殖,哮喘和过敏性疾病(包括特应性皮炎)的发病率较低 以及儿童早期的食物过敏。早期特应性疾病的生物标志物(Babe)将测试整体 特应性皮肤屏障功能紊乱、免疫功能障碍和微生物群导致特应症的假说 皮炎、Th2炎症、过敏性过敏和FA,而健康的肠道微生物群调节 保护代谢物库,如短链脂肪酸和色氨酸代谢物和保护性Treg 免疫发育。项目1利用深度元基因组测序来评估婴儿肠道微生物组 OOM婴幼儿肠道微生物组组成及相应代谢组与城市不同 婴儿。项目2评估变态反应致敏和保护性免疫发展的标志物 多参数谱流、无偏聚类分析和转录研究证明城市 婴儿早期发现高炎性单核细胞和Th2偏斜的T细胞亚群 婴儿期,而OOM有肠道归宿记忆树。项目3将描述皮肤屏障功能, 微生物组和免疫细胞转录组。我们的纵向出生队列ZOOM1,由U01赠款资助,是 现在2-5岁,是三个项目(78个OOM和79个城市)的共同基础。我们将添加另一个 120名婴儿作为ZOM2队列(80名城市婴儿和40名OOM婴儿)。我们还将复制关键的T细胞生物标记物 婴儿队列(开始吃早期饮食种子和微生物组与过敏性哮喘精准预防 “MAAP2”)。招募、收集和共享样本和数据的基础设施由队列管理和 生物仓库和数据管理&生物信息学核心。管理核心将提供总体财务和 行政基础设施。这些研究旨在确定生物标记物、机制和保护策略。 对抗特应性和食物过敏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kirsi Jarvinen-Seppo其他文献

Kirsi Jarvinen-Seppo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kirsi Jarvinen-Seppo', 18)}}的其他基金

Innate and Adaptive Immune Markers in Farming Lifestyle and Early Atopic Diseases
农业生活方式和早期特应性疾病中的先天性和适应性免疫标志物
  • 批准号:
    10633369
  • 财政年份:
    2023
  • 资助金额:
    $ 145.75万
  • 项目类别:
Administration Core
行政核心
  • 批准号:
    10633365
  • 财政年份:
    2023
  • 资助金额:
    $ 145.75万
  • 项目类别:
Expecting Mothers' Study of Consumption or Avoidance of Peanut and Egg (ESCAPE)
准妈妈食用或避免花生和鸡蛋的研究(ESCAPE)
  • 批准号:
    10733927
  • 财政年份:
    2023
  • 资助金额:
    $ 145.75万
  • 项目类别:
Role of B. infantis in Development of Atopic Diseases
婴儿双歧杆菌在特应性疾病发展中的作用
  • 批准号:
    10286718
  • 财政年份:
    2021
  • 资助金额:
    $ 145.75万
  • 项目类别:
Role of B. infantis in Development of Atopic Diseases
婴儿双歧杆菌在特应性疾病发展中的作用
  • 批准号:
    10432099
  • 财政年份:
    2021
  • 资助金额:
    $ 145.75万
  • 项目类别:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
粘膜和系统免疫的发展以及食物过敏的风险
  • 批准号:
    10158965
  • 财政年份:
    2020
  • 资助金额:
    $ 145.75万
  • 项目类别:
Impact of Breast Milk on Infant Gut Microbiome
母乳对婴儿肠道微生物群的影响
  • 批准号:
    9756486
  • 财政年份:
    2018
  • 资助金额:
    $ 145.75万
  • 项目类别:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
粘膜和系统免疫的发展以及食物过敏的风险
  • 批准号:
    10265645
  • 财政年份:
    2017
  • 资助金额:
    $ 145.75万
  • 项目类别:
Impact of Maternal Diet and Supplements on Breast Milk Composition
母亲饮食和补充剂对母乳成分的影响
  • 批准号:
    9912500
  • 财政年份:
    2017
  • 资助金额:
    $ 145.75万
  • 项目类别:
Development of Mucosal and Systemic Immunity and Risk of Food Allergy
粘膜和系统免疫的发展以及食物过敏的风险
  • 批准号:
    9895622
  • 财政年份:
    2017
  • 资助金额:
    $ 145.75万
  • 项目类别:

相似海外基金

Measurement of serum IgE and identification of allergens in seafood allergic patients
海鲜过敏患者血清IgE测定及过敏原鉴定
  • 批准号:
    21K13490
  • 财政年份:
    2021
  • 资助金额:
    $ 145.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of augmentation of contact allergic reactions by irritants and contact allergens
刺激物和接触性过敏原增强接触性过敏反应的机制
  • 批准号:
    335858052
  • 财政年份:
    2017
  • 资助金额:
    $ 145.75万
  • 项目类别:
    Research Grants
Elucidation of conformational epitopes of peanut allergens essential for allergic reactions
阐明过敏反应所必需的花生过敏原的构象表位
  • 批准号:
    8970024
  • 财政年份:
    2015
  • 资助金额:
    $ 145.75万
  • 项目类别:
Environmental allergens affect the function of allergic inflammatory cells
环境过敏原影响过敏性炎症细胞的功能
  • 批准号:
    26860758
  • 财政年份:
    2014
  • 资助金额:
    $ 145.75万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Effects of allergens on dendritic cell function in allergic asthma
过敏原对过敏性哮喘树突状细胞功能的影响
  • 批准号:
    nhmrc : 303161
  • 财政年份:
    2004
  • 资助金额:
    $ 145.75万
  • 项目类别:
    NHMRC Project Grants
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
  • 批准号:
    8348615
  • 财政年份:
    2001
  • 资助金额:
    $ 145.75万
  • 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
  • 批准号:
    8522031
  • 财政年份:
    2001
  • 资助金额:
    $ 145.75万
  • 项目类别:
IImmune Tolerance Network: Airborne Allergens and Allergic Rhintitis
II免疫耐受网络:空气中的过敏原和过敏性鼻炎
  • 批准号:
    8730013
  • 财政年份:
    2001
  • 资助金额:
    $ 145.75万
  • 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
  • 批准号:
    6137243
  • 财政年份:
    1998
  • 资助金额:
    $ 145.75万
  • 项目类别:
ASPERGILLUS ALLERGENS AND ALLERGIC ASPERGILLOSIS
曲霉过敏原和过敏性曲霉病
  • 批准号:
    2462172
  • 财政年份:
    1998
  • 资助金额:
    $ 145.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了